Abstract
Background and objectives
Few studies have reported the association of the use of selective serotonin reuptake inhibitors (SSRIs) with acute pancreatitis. We conducted a population-based case-control study to explore this relationship.
Methods
In this study, 4631 cases with first attack of acute pancreatitis and 4631 controls without acute pancreatitis were selected using a randomly sampled cohort of one million health insurance enrollees from 2000 to 2013. Both cases and controls were aged 20–84 years and were matched with sex, age, comorbidities, and index year of diagnosis of acute pancreatitis. Patients with current use of SSRIs were defined as those whose last tablet of SSRIs was noted ≤ 7 days before the date of diagnosis of acute pancreatitis; patients with late use of SSRIs were defined as those whose last tablet of SSRIs was noted ≥ 8 days before the date of diagnosis; and patients with no use of SSRIs were defined as those who were never prescribed SSRIs. The odds ratio (OR) and 95% confidence interval (CI) for acute pancreatitis associated with the use of SSRIs were assessed using multivariate unconditional logistic regression analysis.
Results
After adjusting for covariables, multivariate logistic regression analysis revealed that compared with patients with no use of SSRIs, the adjusted OR of acute pancreatitis for those with current use of SSRIs was 1.7 (95% CI, 1.1–2.5), whereas that for patients with late use of SSRIs was 1.0 (95% CI, 0.9–1.2) without statistical significance.
Conclusions
Current use of SSRIs is associated with the diagnosis of acute pancreatitis. Therefore, clinicians should consider the possibility of SSRI-associated acute pancreatitis among patients currently taking SSRIs and those presenting with the diagnosis of acute pancreatitis without a definite cause.
Similar content being viewed by others
Abbreviations
- ICD-9 code:
-
International Classification of Diseases 9th Revision Clinical Modification
References
Steer ML (1988) Pathogenesis of acute pancreatitis. Ann Rev Med 39:95–105
Underwood TW, Frye CB (1993) Drug-induced pancreatitis. Clin Pharm 12:440–448
Ohsson K, Balldin G, Bohe M, Borgstrom A, Genell S, Lasson A (1988) Pancreatic proteases and antiproteases in pancreatic disease; biochemical, pathophysiological and clinical aspects. Int J Pancreatol 3:67–78
Steinberg W, Tenner S (1994) Acute pancreatitis. N Engl J Med 17:1198–1210
Faulds D, Brodgen RN (1992) Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs 44:94–116
Sturdevant RA, Singleton JW, Deren JL, Law DH, McCleery JL (1979) Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 77:883–886
Blomgren K, Sundstrom A, Steineck G, Wiholm BE (2002) Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis. Diabetes Care. 25:298–302
Bourke JB, McIllmurray MB, Mead GM, Langman MJS (1978) Drug-associated primary acute pancreatitis. Lancet 1:706–708
Blomgren KB, Sundstrom A, Steineck G et al (2002) A Swedish case-control network for studies of drug-induced morbidity—acute pancreatitis. Eur J Clin Pharmacol 58:275–283
Gonzalez-Flores D, Velardo B, Garrido M et al (2011) Ingestion of Japanese plums (Prunus salicina Lindl. cv. Crimson Globe) increases the urinary 6-sulfatoxymelatonin and total antioxidant capacity levels in young, middle-aged and elderly humans: nutritional and functional characterization of their content. J Food Nutrition Res 50(4):229–236
Young SN (2007) How to increase serotonin in the human brain without drugs. Rev Psychiatr Neurosci 32(6):394–399
Lesch KP, Bengel D, Heils A et al (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274(5292):1527–1531
Barlow, Durand DH, Mark V (2009) Chapter 7: mood disorders and suicide. In: Abnormal psychology: an integrative approach, Fifth edn. Belmont, Wadsworth Cengage Learning, p 239
Yang MD, Lin KC, Lu MC, Jeng LB, Hsiao CL, Yueh TC et al (2017) Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomedicine-Taiwan. 7:18–24
Yang JS, Lu CC, Kuo SC, Hsu YM, Tsai SC, Chen SY et al (2017) Autophagy and its link to type II diabetes mellitus. Biomedicine-Taiwan. 7:1–12
Wu MH, Lee TH, Lee HP, Li TM, Lee IT, Shieh PC et al (2017) Kuei-Lu-Er-Xian-Jiao extract enhances BMP-2 production in osteoblasts. Biomedicine-Taiwan 7:9–15
Liu YL, Liu JH, Wang IK, Ju SW, Yu TM, Chen IR et al (2017) Association of inflammatory cytokines with mortality in peritoneal dialysis patients. Biomedicine-Taiwan. 7:1–8
Lin CH, Lin WC, Chang JS (2017) Presentations and management of different causes of chylothorax in children: one medical center’s experience. Biomedicine-Taiwan. 7:30–34
Ooi H (2016) Bedside pleuroscopy in Taiwan : a great vision for critically-ill patients and intensivists. Biomedicine-Taiwan. 6:1–4
Maa MC, Leu TH (2016) Src is required for migration, phagocytosis, and interferon beta production in toll-like receptor-engaged macrophages. Biomedicine-Taiwan. 6:5–9
Huang YP, Chang NW (2016) PPARalpha modulates gene expression profiles of mitochondrial energy metabolism in oral tumorigenesis. Biomedicine-Taiwan. 6:17–22
Hsu YM, Yin MC (2016) EPA or DHA enhanced oxidative stress and aging protein expression in brain of d-galactose treated mice. Biomedicine-Taiwan. 6:23–30
Hsieh TC, Wu YC, Sun SS, Yen KY, Kao CH (2016) Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review. Biomedicine-Taiwan. 6:1–7
National Health Insurance Research Database. Taiwan. http://nhird.nhri.org.tw/en/index.html. [cited on May 1, 2017, English version]
Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC (2010) Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 89:295–299
Hung SC, Liao KF, Lai SW, Li CI, Chen WC (2011) Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol 11:111
Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ (2012) Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol 96:1368–1371
Cheng KC, Chen YL, Lai SW, Mou CH, Tsai PY, Sung FC (2012) Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol 13:129
Liao KF, Lai SW, Li CI, Chen WC (2012) Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol 27:709–713
Liao KF, Cheng KC, Lin CL, Lai SW (2017) Etodolac and the risk of acute pancreatitis. Biomedicine-Taiwan. 7(1):25–29
Shen ML, Liao KF, Tsai SM, Lin CL, Lai SW (2016) Herpes zoster correlates with pyogenic liver abscesses in Taiwan. Biomedicine-Taiwan. 6(4):24–29
Hung SC, Hung SR, Lin CL, Lai SW, Hung HC (2015) Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. Am J Gastroenterol 110:1490–1496
Lai SW, Lin CL, Liao KF (2016) Atrial fibrillation associated with acute pancreatitis: a retrospective cohort study in Taiwan. J Hepatobiliary Pancreat Sci 23:242–247
Liao KF, Huang PT, Lin CC, Lin CL, Lai SW (2017) Fluvastatin use and risk of acute pancreatitis:a population-based case-control study in Taiwan. Biomedicine-Taiwan. 7:24–28
Lai SW, Lin CL, Liao KF (2017) Risk of contracting pneumonia among patients with predialysis chronic kidney disease: a population-based cohort study in Taiwan. Biomedicine-Taiwan. 7:42–47
Lin HF, Lai SW, Lin WY, Liu CS, Lin CC, Chang CM (2016) Prevalence and factors of elevated alanine aminotransferase in central Taiwan—a retrospective study. Biomedicine-Taiwan. 6(2):25–30. https://doi.org/10.7603/s40681-016-0011-7
Lai SW (2016) Risks and benefits of zolpidem use in Taiwan: a narrative review. Biomedicine-Taiwan. 6(2):9–11. https://doi.org/10.7603/s40681-016-0008-2
Cheng KC, Lin WY, Liu CS, Lin CC, Lai HC, Lai SW (2016) Association of different types of liver disease with demographic and clinical factors. Biomedicine-Taiwan. 6(3):16–22
Lai SW, Lai HC, Lin CL, Liao KF (2015) Finasteride use and acute pancreatitis in Taiwan. J Clin Pharmacol 55:657–660
Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH (2016) Nabumetone use and risk of acute pancreatitis in a case-control study. Pancreatology : official J Int Assoc Pancreatology 16(3):353–357
Lai SW, Lin CL, Liao KF, Lin CY (2015) Amiodarone use and risk of acute pancreatitis: a population-based case-control study. Heart Rhythm 12:163–166
Liao KF, Lin CL, Lai SW, Chen WC (2016) Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan. Eur J Intern Med 27:76–79
Lai SW, Lin CL, Liao KF (2016) Atorvastatin use associated with acute pancreatitis: a case-control study in Taiwan. Medicine 95(7):e2545
Kvande KT, Madsen S (2001) Selective serotonin uptake inhibitors and pancreatitis. Tidsskr Nor Laegeforen 121:177–178
Spigset O, Hagg S, Bate A (2003) Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol 18:157–161
Lancashire RJ, Cheng K, Langman JS (2003) Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther 17:887–893
Norgaard M, Jacobsen J, Gasse C et al (2007) Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study. J Clin Psychopharmacol 27(3):259–262
Ljung R, Ruck C, Mattsson F, Bexelius TS, Lagergren J, Lindblad M (2012) Selective serotonin reuptake inhibitors and the risk of acute pancreatitis—a Swedish population-based case-control study. J Clin Psychopharmacol 32:336–340
Kirchgessner AL, Gershon MD (1995) Presynaptic inhibition by serotonin of nerve-mediated secretion of pancreatic amylase. Am J Phys 268(2 Pt 1):339–345
Li Y, Wu XY, Zhu JX et al (2001) Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol 281(4):916–923
Masuda M, Miyasaka K, Funakoshi A (1997) Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious rats. J Auton Nerv Syst 62(1–2):58–62
Coulie B, Tack J, Bouillon R et al (1998) 5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans. Am J Phys 274(2 Pt 1):317–320
Yoshino T, Yamaguchi I (1997) Possible involvement of 5-HT2 receptor activation in aggravation of diet-induced acute pancreatitis in mice. J Pharmacol Exp Ther 283(3):1495–1502
Jain P, Nijhawan S, Rai RR et al (2007) Acute pancreatitis in acute viral hepatitis. World J Gastroenterol 13:5741–5744
Eland IA, Rasch MC, Sturkenboom MJ et al (2000) Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology 119:230–233
Chaudhari S, Park J, Anand BS et al (2004) Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci 49:1000–1006
Funding information
This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial Center (MOHW106-TDU-B-212-113004), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10601010036), Taiwan Clinical Trial Consortium for Stroke (MOST 106-2321-B-039-005), Tseng-Lien Lin Foundation in Taichung in Taiwan, Taiwan Brain Disease Foundation in Taipei in Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds in Japan. These funding agencies did not influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
Hsien-Feng Lin and Kuan-Fu Liao substantially planned and conducted this study, participated in the data interpretation, and also critically revised the article.
Ching-Mei Chang and Cheng-Li Lin conducted the data analysis and critically revised the article.
Shih-Wei Lai substantially planned and conducted this study, contributed to the conception of the article, initiated the draft of the article, and critically revised the article.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Lin, HF., Liao, KF., Chang, CM. et al. Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan. Eur J Clin Pharmacol 73, 1615–1621 (2017). https://doi.org/10.1007/s00228-017-2328-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2328-x